Capstone Investment Advisors
GMED icon

Capstone Investment Advisors’s Globus Medical GMED Stock Holding History

Capstone Investment Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,612
Closed -$397K – 1764
2026
Q1 		$397K Buy
+4,612
New +$414K ﹤0.01% 1252
2024
Q2 		– Sell
-5,747
Closed -$308K – 2226
2024
Q1 		$308K Buy
+5,747
New +$309K ﹤0.01% 1822
2017
Q2 		– Sell
-27,677
Closed -$819K – 740
2017
Q1 		$819K Buy
+27,677
New +$755K 0.02% 474
2016
Q4 		– Sell
-13,300
Closed -$300K – 1005
2016
Q3 		$300K Sell
13,300
-5,339
-29% -$125K 0.01% 605
2016
Q2 		$444K Sell
18,639
-2,394
-11% -$57.4K 0.01% 493
2016
Q1 		$499K Buy
+21,033
New +$514K 0.02% 423

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capstone Investment Advisors's GMED Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 4,612 shares — an estimated $397K sold.

Capstone Investment Advisors first reported a position in GMED in Q1 2016 and held it in 6 quarters. The position peaked at $819K in Q1 2017. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 4,612 Globus Medical shares in Q2 2026, an estimated $397K.
  • Capstone Investment Advisors first reported a position in Globus Medical in Q1 2016 and held it in 6 quarters.
  • Capstone Investment Advisors's Globus Medical position peaked at $819K in Q1 2017.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.